Preferred Label : caprelsa;
Obsolete resource : false;
Origin ID : M0593442;
UMLS CUI : C3162407;
Related record
- Semantic type(s)
https://www.has-sante.fr/portail/jcms/c_2912132/fr/caprelsa
2019
false
true
false
false
France
administration, oral
treatment outcome
vandetanib
insurance, health, reimbursement
protein kinase inhibitors
adult
adolescent
child
thyroid cancer, medullary
neoplasm metastasis
caprelsa
piperidines
quinazolines
evaluation of the transparency committee
vandetanib
piperidines
quinazolines
carcinoma, neuroendocrine
thyroid neoplasms
---
